This approach minimizes FAK-driven escape while capitalizing on tissue-specific roles of PYK2, such as its tumor-suppressive function in GC versus oncogenic actions in PDAC/HCC (38, 62). The gene discussed is PTK2B; the disease is hepatocellular carcinoma.